<DOC>
	<DOC>NCT00442546</DOC>
	<brief_summary>Pregabalin added to the standard of care with dosing starting preoperatively and continuing for up to 6 weeks post surgery will decrease the intensity of post-operative pain following total knee replacement.</brief_summary>
	<brief_title>Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Subjects with osteoarthritis (OA) undergoing elective TKA under regional anesthesia (neuroaxial with or without peripheral nerve block). Subjects able to demonstrate sufficient psychomotor dexterity and cognitive capacity to use Patient Controlled Analgesia/Patient Controlled Epidural Analgesia if used as part of the standard of care. The subject's preoperative health is graded as American Society of Anesthesiology Class 1 to Class 3 Subjects undergoing revision, unicompartmental, bilateral total knee arthroplasty or subjects with planned second knee total knee arthroplasty at time of present procedure. Subjects with inflammatory arthritides (i.e., rheumatoid arthritis, lupus, ankylosing spondylitis, psoriatic arthritis); Lyme disease. Subjects with fibromyalgia and or other chronic pain syndromes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>opioid</keyword>
</DOC>